Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treosulfan-based Conditioning Therapy Prior to Allogeneic Stem Cell Transplantation in Hematological Malignancies
NCT01063647Phase 2Completed
- Sponsor
- medac GmbH
- Start
- Nov 2001
- Primary completion
- Jun 2005
- Countries
- 4
01
Overview
A Phase 2 trial of treosulfan in hematological malignancy, sponsored by medac GmbH. Started Nov 2001; status: completed.
02
Drugs
treosulfan
03
Conditions
hematological malignancy
Beyond the preview
Go deeper on NCT01063647.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01063647.